Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hydrogen
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : Taoyuan Armed Forces General Hospital | Tri-Service General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 07, 2024
Lead Product(s) : Hydrogen
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : Taoyuan Armed Forces General Hospital | Tri-Service General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydrogen
Therapeutic Area : Immunology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 19, 2022
Lead Product(s) : Hydrogen
Therapeutic Area : Immunology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydrogen
Therapeutic Area : Immunology
Study Phase : Phase I
Sponsor : Tri-Service General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
November 10, 2021
Lead Product(s) : Hydrogen
Therapeutic Area : Immunology
Highest Development Status : Phase I
Sponsor : Tri-Service General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable